Inside Operation Warp Speed’s $26b sprint for a vaccine
It's expensive, secretive and America's best chance of emerging from the economic and health crisis that played such a big role in the election.
On a late August day in an industrial corner of Baltimore that had been mostly silenced by the pandemic, a red-brick factory was buzzing with activity.
Deep in the building, in a zone called Area 3, the stainless steel shell of a bioreactor lay on its side, having just arrived from Massachusetts. Employees had begun the task of making the bioreactor operational. Within weeks it would be the centre of a production line for coronavirus vaccines.
Bloomberg Businessweek
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In North America
Fetching latest articles